Cargando…
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834295/ https://www.ncbi.nlm.nih.gov/pubmed/36631450 http://dx.doi.org/10.1038/s41408-022-00771-w |
| _version_ | 1784868430933917696 |
|---|---|
| author | Zu, Yingling Gui, Ruirui Li, Zhen Wang, Juan Zhang, Yanli Yu, Fengkuan Zhao, Huifang Zhan, Xinrong Wang, Zhongliang Xing, Pengtao Wang, Xianjing Wang, Huili Song, Yongping Zhou, Jian |
| author_facet | Zu, Yingling Gui, Ruirui Li, Zhen Wang, Juan Zhang, Yanli Yu, Fengkuan Zhao, Huifang Zhan, Xinrong Wang, Zhongliang Xing, Pengtao Wang, Xianjing Wang, Huili Song, Yongping Zhou, Jian |
| author_sort | Zu, Yingling |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9834295 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98342952023-01-13 Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial Zu, Yingling Gui, Ruirui Li, Zhen Wang, Juan Zhang, Yanli Yu, Fengkuan Zhao, Huifang Zhan, Xinrong Wang, Zhongliang Xing, Pengtao Wang, Xianjing Wang, Huili Song, Yongping Zhou, Jian Blood Cancer J Correspondence Nature Publishing Group UK 2023-01-11 /pmc/articles/PMC9834295/ /pubmed/36631450 http://dx.doi.org/10.1038/s41408-022-00771-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Zu, Yingling Gui, Ruirui Li, Zhen Wang, Juan Zhang, Yanli Yu, Fengkuan Zhao, Huifang Zhan, Xinrong Wang, Zhongliang Xing, Pengtao Wang, Xianjing Wang, Huili Song, Yongping Zhou, Jian Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| title | Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| title_full | Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| title_fullStr | Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| title_full_unstemmed | Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| title_short | Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| title_sort | low-dose ptcy plus low-dose atg as gvhd prophylaxis after ud-pbsct for hematologic malignancies: a prospective, multicenter, randomized controlled trial |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834295/ https://www.ncbi.nlm.nih.gov/pubmed/36631450 http://dx.doi.org/10.1038/s41408-022-00771-w |
| work_keys_str_mv | AT zuyingling lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT guiruirui lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT lizhen lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT wangjuan lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT zhangyanli lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT yufengkuan lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT zhaohuifang lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT zhanxinrong lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT wangzhongliang lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT xingpengtao lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT wangxianjing lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT wanghuili lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT songyongping lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial AT zhoujian lowdoseptcypluslowdoseatgasgvhdprophylaxisafterudpbsctforhematologicmalignanciesaprospectivemulticenterrandomizedcontrolledtrial |